Havah Therapeutics
Longmont, US · Founded 2023
Biotech
Founders & leadership
RM
Ronald MartellDirector
MB
Matthew BrewerExecutive Officer, Director
JW
Jim WeissDirector
Reported raises · per SEC filings
Form D private placements▶$507.4KraisedMay 2024 · 14 investors · PharmaceuticalsRule 506(b)
▶$507.4KraisedMay 2024 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ronald MartellDirector
- Matthew BrewerExecutive Officer, Director
- Jim WeissDirector
- Offering amount
- $507.4K
- Amount sold
- $507.4K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.